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Abstract
Background: Achalasia is a rare motility disorder affecting the oesophagus, which is 
associated with a range of symptoms and different treatment strategies. Currently, 
little is known about people's experiences with achalasia and its management. This 
study aimed to understand the experiences of people living with achalasia, from the 
initial onset of symptoms to long-term management.
Method: This qualitative study explored the journey of people living with achalasia 
and outlined the care pathway using a process map. Ten female and five male partici-
pants living with achalasia (age range: 40-73) took part, and all aspects of their diag-
nosis, treatment and management were discussed. A process map showing people's 
experiences by separating the management of their condition into a series of steps 
was developed to present the pathway in the participants’ journey. The analysis in-
volved discussing the process map within the research team.
Results: The process map comprised of 10 steps, which occurred before and after di-
agnosis. The developed map indicates that most participants managed their on-going 
symptoms through stress management techniques and dietary changes. Key issues 
that participants highlighted about their journey managing achalasia were misdiagno-
sis, delay in diagnosis and lack of support in the long-term management of achalasia.
Conclusions: This research was a novel study exploring patients’ experiences and 
management of achalasia and mapping their journey. Two distinct phases to their 
journeys were identified: before and after diagnosis. Areas highlighted by this study 
can provide a basis for future research, in particular behaviour change to support the 
long-term management of achalasia.
K E Y W O R D S
Achalasia, chronic condition, diet, patient experiences, process map, rare condition, self-
management, stress
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1  | INTRODUC TION
Achalasia is a rare motility disorder affecting the oesophagus. 
This condition can start at any time of life but is more common 
in middle-aged or older adults.1 It is equally prevalent in males 
and females, with an overall incidence of 1.63 cases per 100 000 
people.2,3 The underlying causes of achalasia are unknown.1 
Characteristic features, such as a non-relaxing sphincter, weak or 
absent oesophageal peristalsis and simultaneous or poorly coordi-
nated contraction, lead to an outflow obstruction at the level of the 
lower oesophageal sphincter (LOS). The presence of these features 
leads to difficulty in swallowing, particularly with liquids before 
solids, as well as a variety of other associated symptoms. Patients 
can present with several years’ history of progressive symptoms, 
or acutely with a range of symptoms such as complete dysphagia, 
regurgitation and progressive weight loss.1 The symptom onset is 
typically insidious and usually progress over many years, and it has 
a substantial impact on quality of life.2 The diagnosis of achalasia 
can be confirmed by different diagnostic tests such as endoscopy, 
barium swallow and manometry.1 Despite it being a crippling con-
dition, about 20-50% of cases are initially misdiagnosed, with pa-
tients given an alternative diagnosis such as gastro-oesophageal 
reflux disease or hiatus hernia.4 Treatments for achalasia are often 
delayed due to a lack of diagnosis, and even the most effective 
treatments usually do not achieve a cure.2 Therefore, in a large 
proportion of patients, the initial treatment is either delayed or in-
appropriate and ineffective.5 Moreover, as the cause of achalasia is 
unknown, treatment has focused on alleviating the symptoms and 
their consequences. There are different treatment options avail-
able for achalasia such as medications, Botox injections, balloon 
dilatation, surgical interventions and non-medical interventions 
such as behavioural changes. It is therefore critical that people with 
achalasia learn to self-manage their symptoms (to some degree).
Behavioural and lifestyle adjustments are required for success-
ful management of chronic conditions.6 Chronic disease manage-
ment is typically conducted by the patient in their day-to-day life; 
however, their interaction with health-care providers is a critical 
intersection for information exchange, decision making and mo-
tivation.7 Chronically ill patients have to manage their daily living 
under different financial and social constraints, and their associated 
symptoms can complicate the most routine activities of daily living.7 
According to a study carried out by Clark et al,8 three separate cat-
egories of activities need to be addressed in order to successfully 
self-manage a chronic condition.8 First, people with chronic condi-
tions need to have an adequate knowledge about their condition 
and its treatment to make informed decisions. Second, they need 
to perform activities in order to manage their condition by making 
changes to their lifestyle, including changing their dietary habits. 
Third, they need to apply skills to maintain adequate psychosocial 
functioning, which includes working, maintaining a good family life 
and cultivating social relationships.8 These self-management activ-
ities aim to reduce the impact of chronic conditions on daily life.
It is challenging to live with any chronic condition, in partic-
ular a rare disease such as achalasia. The general public often 
shows sympathy and understanding when someone lives with a 
visible or well-known disease; however, living with a rare or less 
visible disease generates different challenges for individuals and 
those who interact with them.9 Knowledge, coping strategies and 
problem-solving skills are factors that enhance adjustment and 
adaptation to a long-term chronic condition.9 A better under-
standing of their condition helps people to cope with the anxi-
ety and uncertainty, while lack of knowledge leads to a sense of 
powerlessness.10
Health-care professionals who do not have the knowledge 
to diagnose a rare disease may mistakenly label their patients as 
‘psychological cases’ rather than persons having an individualized 
physical illness.9 This is demonstrated in results from the study of 
another rare condition, scleroderma, in which nurses with very lit-
tle knowledge about this rare condition stigmatized individuals by 
ignoring the signs and symptoms of the condition and labelling them 
as ‘untrustworthy’.9 Stigma can produce a sense of fear and rejection 
among people with such a health condition.9 This is further evident 
historically where, for example, people with epilepsy were stigma-
tized as dangerous or violent due to a lack of knowledge amongst 
the general public.6
Exploring people's experiences can be a valuable way of provid-
ing first-hand information about their care pathways. There is often 
a lack of appropriate health services, effective treatment options 
and skilled health professionals for rare conditions.11 Patients can be 
the best source of information to give appropriate suggestions relat-
ing to their experiences and areas of their care which need improve-
ment.11 Rare diseases have a significant psychological and emotional 
impact on patients and their families, which is often followed by a 
lack of appropriate community and peer support.11 Research has 
explored different treatment options for achalasia in terms of their 
effectiveness, but the focus has not been on the patient's experi-
ence and in particular the individual's journey along their pathway. 
The current study thus aimed to map the experiences of people 
living with achalasia from diagnosis through to long-term manage-
ment and to suggest where further input is needed from health-care 
professionals.
2  | METHOD
2.1 | Design
An exploratory qualitative study using a process map was conducted. 
Quantitative studies such as surveys were not appropriate as this 
was exploratory work. The data provided in the mapping sessions 
can be used to improve patient pathways.12 This study involved in-
depth, semi-structured mapping sessions to explore and understand 
the care pathways for people living with achalasia and the long-term 
management of this condition. This study used a phenomenological 
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approach to describe the lived experiences of people with achalasia 
13 and allow the researcher to understand and gain rich details on an 
unknown area.
2.2 | Methodology
This study involved three mapping sessions, which were conducted 
in London, United Kingdom. The research materials, including the 
topic guide and draft map, were prepared by the research team 
before each session. A process map was produced in each ses-
sion, and information was added cumulatively. The process map 
produced in the final session included all the steps involved in the 
participant journey, which was discussed in the three sessions 
from the first onset of the symptoms through to the on-going 
management of achalasia. The final process map was discussed 
and refined within the research team. A favourable ethical opinion 
was granted through the University of Reading Research Ethics 
Committee (UREC-13/38).
2.3 | Paradigm underpinning the methodology
Constructivism was the approach used to interpret the data that 
were collected in the sessions. This approach considers that there 
could be multiple interpretations of an event, shaped by the re-
searcher's historical or social perspective in comparison with posi-
tivism, which adheres to the factual knowledge gained through 
observation and measurements.14 This research was a qualitative 
study to understand a particular phenomenon; therefore, data were 
interpreted based on the researcher's expertise.14 In this approach, 
it is acknowledged that the researcher interprets the data based on 
their own understanding and knowledge developed through their 
own experiences.15 The researchers facilitated the sessions using 
prompts to elicit the participants’ experiences. Through the analy-
sis, the researchers constructed meaning from the data based upon 
their previous knowledge and research to produce the final process 
map.
2.4 | Recruitment
Participants were recruited through the Achalasia Support Group 
affiliated with Achalasia Action, an independent charity supporting 
people living with achalasia in the United Kingdom (UK). This is a 
national group, with over 400 members, based in London and run by 
members of the public living with achalasia. People usually find and 
join this group through searching on the Internet and word of mouth. 
Convenience sampling was the strategy used to recruit participants 
based on their willingness and availability to take part. The inclusion 
criteria for this study were as follows: anyone living in the UK, aged 
18 years or over, with a confirmed diagnosis of achalasia, who con-
sented to take part, was able to attend a session and spoke English. 
The researcher emailed the recruitment materials, which included 
an information sheet and consent form, to the administrator of the 
support group who distributed these through the support group 
mailing list inviting members to participate. Participants were asked 
to contact the researcher (MK) with their interest in taking part in a 
mapping session.
2.5 | Data collection
Before the first session, a basic draft of a process map was pro-
duced by the researcher based on preliminary research,16 which 
involved interviewing individuals living with achalasia about their 
experiences. Based on the preliminary research, the draft process 
map consisted of three main stages, which were pre-diagnosis, di-
agnosis and after diagnosis to facilitate discussion in the mapping 
sessions. The draft process map was used to provide structure to 
the discussion.
2.6 | Process mapping sessions
Participants in the current study were allocated to one of the three 
mapping sessions based on their availability. Mapping sessions were 
held over a month with a maximum of eight people in each session. 
The aim of the study, the structure of the session and the topics for 
discussion were stated at the beginning of each session. The ground 
rules were explicitly stated and included confidentiality, raising con-
cerns during sessions and the option to withdraw from participation. 
After their consent had been obtained at the beginning of each ses-
sion, participants were given a brief demographic questionnaire ask-
ing their sex, age, living status (living alone or co-habiting) and the 
type of medical interventions they had received for achalasia. The 
sessions lasted around 90-120 minutes and were audio-recorded for 
accuracy check purposes.
In each session, participants were asked to talk through their 
journey from the first onset of their symptoms through to the on-go-
ing management. The researchers provided prompts to participants 
and recorded their experiences. Two researchers were present at 
each session to ensure all the points that were raised were doc-
umented. At the end of each session, the researchers checked all 
points raised were documented and then participants were provided 
with stickers to add to the discussion board to highlight the most 
challenging steps in their journey. The collected data in the mapping 
sessions produced a process map, and the recordings were used for 
accuracy check purposes only. Participant quotes were not tran-
scribed and included in the process maps as the main aim of this 
study was to explore the overall care pathways and steps involved in 
people's journey living with achalasia. In this methodology, data are 
collected in real time and a process map is created in the mapping 
sessions. Two female researchers facilitated each session. Session 1 
was run by two pharmacist researchers, and the following sessions 
were run by a pharmacist and a health psychologist.
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2.7 | Data analysis
The collected data were discussed within the research team after 
each session. The content with similar ideas or concepts was 
grouped and then assigned headings corresponding to key steps in 
people's journeys, resulting in a more detailed and informative draft 
map for the second session. The process map and its contents were 
edited and analysed through listening repeatedly to the recordings. 
Recordings were reviewed to check the accuracy of the process map, 
and they were listened to repeatedly to identify the steps and the 
iterative process of people's journeys. Findings were analysed by 
the research team to address the aim of the research. The analy-
sis involved discussing the findings based on the number of steps in 
their journey, number of times the patients had been sent from one 
health-care professional to another, time taken in and between each 
step, steps that added no value for the participants and areas where 
problems were raised for them.17 Through this analysis, process map 
was developed and validated by the participants in the final session 
where participants were asked to confirm whether the process map 
was an accurate representation of their journey. Data saturation was 
achieved in the final session. Data saturation is reached when there 
is enough information to replicate the study and when the ability to 
gain additional new information has been attained.18 The final pro-
cess map is the end product of the analysis, and it gives an outline 
of the findings. The researchers created the final process map it-
eratively by analysing the constructs in detail to develop a map that 
most accurately represents the participants’ journey. The final de-
veloped process map presents the discrete steps in a participant's 
journey in the order in which they occurred.
3  | RESULTS
3.1 | Sample
This study included 15 participants (5 males and 10 females) with 
achalasia. The participants ranged in age from 40 to 73 years (mean 
56). One person contacted the researcher and then decided not to 
take part due to the group setting involved in the mapping session. 
Most participants were white British, and living with a partner, fam-
ily or friend (co-habiting) (see Table 1 for demographic details of the 
participants). Disease management reported by participants ranged 
from a year to 20 years. Two participants participated in session 1, 
eight in session 2 and five in session 3.
3.2 | Overview of findings
Participants provided rich insights into their journey living with acha-
lasia. Figure 1 shows the key steps in the participants’ journeys. The 
results show that there were two main phases (before and after di-
agnosis) with 10 steps in total. These steps were as follows: 1. symp-
toms; 2. management; 3. seeking medical help; 4. diagnosis based 
on the symptoms experienced; 5. return to GP; 6. sent for tests; 7. 
offered treatments; 8. post-treatment complications or symptoms; 
9. on-going management; and 10. general impacts. These steps were 
the headings used in the mapping sessions and provide the structure 
for this results section. The process map created after the three ses-
sions was the end product, and the rich details led to developing 
the process map. Similarities were identified amongst participants’ 
responses in the onset of the symptoms, the tests they received for 
diagnosis and the treatments offered. Key issues that participants 
highlighted included the initial misdiagnosis, the delay in receiving 
the diagnosis and the lack of additional support throughout their 
journey. Figure 1 is the final version of the process map, illustrating 
a summary of the participants’ journey with achalasia from the first 
signs and symptoms through to on-going management.
3.3 | Before diagnosis
Apart from a few participants who visited a private health-care 
professional, the majority of the participants visited their National 
Health Service (NHS) general practitioner (GP). Due to the similarity 
of the symptoms of achalasia to other conditions, participants were 
often given treatment for another condition, which was unsuccess-
ful. They became stuck in a loop where they had to repeatedly visit 
their NHS GP until being sent for an appropriate test and referred to 
a specialist for diagnosis. Participants who visited a private health-
care professional reported obtaining a diagnosis quicker as they 
were sent for the appropriate diagnostic tests immediately.
TA B L E  1   Participants’ demographics
Participant's demographics All participants (n = 15)
Sex Male n = 5 (33%)
Female n = 10 (67%)
Age (years) Mean (SD) 56.2 (13.3)
Range 40-73
Ethnicity White n = 15 (100%)
Living status Living alone n = 4 (27%)
Co-habiting n = 11 (73%)
Employment status Full time n = 5 (33%)
Part time n = 3 (20%)
Retired n = 5 (33%)
Not working n = 1 (7%)
Not stated n = 1 (7%)
Medical treatment Multiple 
treatments 
(medication 
and/or 
surgery)
n = 4 (27%)
Single 
treatment
n = 8 (53%)
No treatment n = 2 (13%)
Not stated n = 1 (7%)
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3.3.1 | Symptoms experienced by participants 
before diagnosis
The majority of participants experienced a range of symptoms ini-
tially, such as chest pain, regurgitation, difficulty swallowing and 
heartburn. Some also reported experiencing recurrent burping, 
breathlessness and choking.
3.3.2 | Pre-diagnosis management
After initially experiencing symptoms, people with achalasia took 
two different routes, with some seeking medical help to find 
out the underlying cause of their symptoms and the rest taking 
actions to self-manage their symptoms. Some people tried to 
manage their symptoms by buying over-the-counter medicines, 
including indigestion remedies such as Rennie or Ranitidine. 
Some addressed them indirectly simply by adjusting their diet un-
consciously and eating what they found easier to swallow. One 
participant reported ‘googling’ her symptoms to find the underly-
ing cause.
3.3.3 | Seeking medical help
After attempting to self-manage their condition, participants re-
ported seeking medical help and visiting their GP when there was 
no improvement in their symptoms and the symptoms persisted. 
The majority of participants visited their GP through the NHS to 
obtain a diagnosis. Other participants, however, sought medical 
help through their private medical insurance. Those who went to a 
private health-care professional reported getting a diagnosis earlier 
than those who accessed a GP via the NHS.
3.3.4 | Misdiagnosis and treatment
Symptoms experienced by people with achalasia are very similar to 
other conditions; therefore, it was often misdiagnosed. Aortic aneu-
rysm, acid reflux, angina and hiatus hernia were a few common con-
ditions that people were diagnosed with at their many visits to the 
GP. They were getting treatments for these conditions but had to go 
back to their GP repeatedly due to on-going issues such as not being 
able to eat or drink, experiencing painful spasms and losing weight.
3.3.5 | Return to GP
Participants revisited their GP many times before being referred to 
a specialist and sent for appropriate tests to get a diagnosis. One of 
the participants reported having to demonstrate how she struggled 
to swallow water before being sent for tests. After multiple visits 
to their GP, participants were eventually referred to address their 
symptoms. The initial referral varied, with participants, referred to 
an oncologist, ENT (ear, nose and throat) specialist or gastroenter-
ologist or sent directly for tests.
3.3.6 | Sent for tests
The common tests which almost all participants were sent in vary-
ing order included barium swallow, endoscopy, manometry and 
F I G U R E  1   Process map of participants’ journey
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computerized tomography (CT) scan. After undergoing several tests, 
participants reported receiving a diagnosis and being offered treat-
ments to choose from.
3.4 | After diagnosis
Once participants obtained a diagnosis, they were offered a medi-
cal intervention, such as endoscopic Botox injection, endoscopic 
balloon dilatation or laparoscopic Heller's myotomy. Participants ei-
ther chose to undergo a procedure or manage their condition with 
non-medical interventions (such as dietary changes). Once partici-
pants had an understanding of the condition, they attempted to self-
manage. Participants had to change their dietary habits, such as the 
timing of their meals or choosing foods that were easier to swallow, 
and also tried changing their posture at night by sleeping in a more 
upright position. At this time, participants had a few options, includ-
ing choosing one or more treatments, managing their condition by 
behavioural changes, accessing information about their condition, 
and joining an online support group to get more help. They also re-
ported issues such as struggling to find accurate information on the 
management of their symptoms and insufficient support from the 
health-care team after diagnosis.
3.4.1 | Offered treatment
Only one participant reported a significant delay in communication 
receiving a diagnosis from her GP after the diagnostic tests. Many 
reported that health-care professionals offered only endoscopic or 
surgical treatments, instead of any lifestyle or behavioural changes 
that could have benefited them in the on-going management of 
their condition. Participants also emphasized a lack of support and 
communication from health-care professionals at this stage. Most 
of the participants were not satisfied with the level of information 
provided about the treatment options from the clinicians, or with the 
aftercare they received from the nurses at the hospital they visited. 
Only one participant reported managing their condition with no fur-
ther medical or surgical treatment.
3.4.2 | Post-treatment complications or symptoms
Participants, in general, complained about the lack of follow-up and 
monitoring after treatment. They believed they were more suscep-
tible to illnesses due to inability to consume nutritious food. Almost 
all participants reported that the treatments did not resolve their 
symptoms completely and that they were still experiencing symp-
toms such as heartburn, indigestion and pain. Some participants 
experienced repeated treatments, whereas others continued to self-
manage their symptoms. At this stage, self-management included 
taking over-the-counter products such as indigestion remedies (eg 
Gaviscon), exercise (eg tai chi and yoga) and dietary changes.
3.4.3 | On-going management
Participants sought to manage their condition through self-manage-
ment, using behavioural and medical strategies. Some participants 
reported changing behaviours such as their diet and lifestyle, while 
others were taking therapeutic medicines such as anti-depressants 
and cannabis oil to cope with their condition. The majority of partici-
pants used a combination of strategies to reduce the recurrence of 
symptoms. Almost all reported educating themselves by searching 
online and communicating with other members of the online support 
group. The on-going management of their condition was reported 
as one of the most crucial points in the journey, as support was re-
quired in the long-term.
3.4.4 | General impacts on day-to-day living
Participants referred to achalasia as a hidden disability, an unseen 
illness that has a significant impact on social life and employability. 
Achalasia significantly affected their lives, and they reported feel-
ing anxious, stressed, exhausted and depressed, which meant they 
could not perform their daily tasks as they would have liked.
4  | DISCUSSION
This is the first study to the authors’ knowledge that explored peo-
ple's experiences of living with achalasia using a process map. People 
living with achalasia experience a complicated journey from seek-
ing a diagnosis through to post-diagnosis. The complexity of their 
journey is mainly due to the ambiguity of symptom presentation, 
lack of knowledge from doctors and the rarity and chronic nature 
of the condition. There is no one way to manage the symptoms of 
achalasia; therefore, people living with this condition need to man-
age their symptoms by trying different self-management strategies 
through trial and error. The key findings of this study were the steps 
involved in people's journey living with achalasia and the areas in 
their journey which participants found difficult. These key areas 
were the delayed diagnosis and the difficulties they experience in 
the on-going symptoms management, specifically the lack of sup-
port from health-care professionals involved in their care. These 
were the areas where an intervention could be implemented to help 
them in the on-going long-term management of this condition. This 
study also highlighted the lag in the initial stages where people with 
achalasia are misdiagnosed, and they make multiple visits to the doc-
tors to receive a diagnosis. The key message of this novel study is 
despite different successful evidence-based medical interventions 
people living with achalasia continue to experience symptoms, such 
as reflux and pain, and have to self-manage their condition. This is a 
potential area that an intervention could be developed and imple-
mented to support the on-going long-term management of achalasia.
Before receiving a diagnosis, people had to deal with uncertainty 
and anxiety. Furthermore, as they did not know what they were 
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living with, the lack of knowledge about their condition led to a feel-
ing of helplessness. Most were stuck in a loop of obtaining a misdiag-
nosis, with treatment directed towards the symptoms based on the 
erroneous diagnosis. Many discussed how not knowing about the 
condition and its underlying causes and treatments made them anx-
ious. Continued uncertainty about a condition can affect the quality 
of life, for example by increasing levels of depression and emotional 
distress.19 Mishel et al defined uncertainty as to the inability to de-
termine the meaning of illness-related events which arises when 
there is a lack of information to understand one's illness, treatment 
and side-effects.20 They also defined uncertainty as to when individ-
uals are unable to use health-care professionals or related support 
to obtain knowledge which they need in order to develop a strategy 
for coping with an unfamiliar situation.20 Our empirical for achalasia 
patients are consistent Mishel et al theoretical account of uncer-
tainty. In chronic conditions, the experience of uncertainty spreads 
to wider life issues. Familiar routines are disrupted and perceptions 
of the order of life are altered.21
Self-management was a common approach in all the steps in-
volved in the journey of patients with achalasia from before diagnosis 
to after treatment. Participants described a range of self-manage-
ment strategies, including medical and behavioural adjustments, such 
as dietary changes, to cope with their condition, even though some 
had undergone successful medical or surgical treatments. Achalasia 
patients need to self-manage as do people with other chronic con-
ditions as shown in previous research. Corbin and Strauss suggest 
three self-management tasks for chronic illnesses: behavioural man-
agement (adjusting lifestyle), emotional management (managing 
anger, fear or frustration) and medical management (taking medi-
cation).22 They recommend to accomplish these tasks, and people 
with chronic conditions ought to apply core self-management skills, 
such as problem-solving, decision making, resource utilization, tak-
ing action and partnership with health-care providers.21 Participants 
in our study also reported using these core skills to a varying extent 
through their journey. In a study on HIV, eight main categories of 
self-management strategies emerged: (a) take medication or treat-
ment; (b) modify activity; (c) alter food in the diet; (d) seek help; (e) 
wait; (f) substance use; (g) manage thoughts or attitude; and (h) alter 
physical environment.23 These self-management strategies were 
also described by the participants in our study suggesting some core 
management approaches across disease types.
After diagnosis, participants were offered different treatment 
options. Their treatment choices were based mainly on the health-
care professional's advice and recommendations, along with, to 
some extent, on the minimal information available to participants 
regarding treatments. The International Society for Disease of the 
Oesophagus developed a guidelines in 2018 intending to offer cli-
nicians and patients an up-to-date framework for making informed 
decisions on the management of this rare condition.24 Fifty-one 
experts from 11 countries and three representatives from patient 
support associations participated in preparing these guidelines. Even 
though the consensus agreement score of the available treatments 
was more than 80% and most of the available treatments were 
considered successful, the majority of patients who participated in 
developing the guidelines were still experiencing symptoms after 
undergoing treatment.24 Achalasia, like many other chronic condi-
tions, requires on-going treatment and continuous self-management 
as it has no cure and the available treatments serve only to allevi-
ate the symptoms. Patients attempt to use a variety of personal, 
social and health-care resources to lessen the treatment burden.25 
The results of our study are consistent with other evidence which 
links social support, optimism and spirituality to better well-being in 
chronic conditions.25 Therefore, although the available treatments 
are reported to be more than 80% successful, they are not 100% 
effective in all patients. The process map produced in this study 
maps out the journey of patients and gives an insight to health-care 
professionals to see what patients go through from the first onset of 
their symptoms to the on-going management of achalasia. The pro-
duced process map can also be a useful decision aid for health-care 
professionals. Moreover, it can assist health-care professionals for 
better shared decision making.
4.1 | Strengths and limitations
The mapping process in this study allowed the researchers to re-
ceive first-hand and in-depth insight into participants’ experiences 
with this rare chronic condition. Process mapping is a useful method, 
which has not previously been used to understand patient's expe-
riences living with achalasia by separating the management of the 
condition into a series of steps allowing the researcher to see the 
sequence of steps involved in their care pathway. It is an interactive 
approach that collects ideas from people who are involved in the 
same process. The data collected for producing the process map can 
be used to redesign patient pathways and improve the quality or ef-
ficiency of management of a disease such as achalasia and alter the 
focus of care towards activities that are most valued by patients. The 
nature of this method let participants discuss their journey within a 
group setting and collect ideas from a group of people, which re-
sulted in the end product of the process map that interviews alone 
would not allow. Participants were asked to talk about their journey 
from before diagnosis through to the on-going management, with 
further details added in each session. People in the last session con-
firmed that the developed map was an accurate representation of 
their journey. The current study explored a rare condition using qual-
itative methods to gain an insight into the steps involved in people's 
journey. The process map provides structure and enables evaluation 
of the steps involved in their journey.
There were several limitations to this research. Although the 
sample size was small, it was appropriate for the method used17; 
future research may use a quantitative approach such as question-
naires to access the experiences of people with achalasia outside 
the UK in a larger scale. Participants were recruited through a 
support group, which provides the opportunity for its members to 
share experiences and tips with others; their on-going disease man-
agement may, therefore differ from that of people who are not part 
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of such a support group. People were asked to attend and engage in 
an in-depth mapping session and share sensitive information about 
a significant period in their lives, and this could affect how they re-
ported certain events. The voluntary nature of participation meant 
that people who took part may have had a different experience to 
others who are not willing to participate in research. The results 
presented in this paper are solely based on what was described in 
the sessions and the interpretation of the researchers, and its find-
ings should, therefore, be viewed from that perspective.
With regard to credibility, the multidisciplinary background 
of the research team enables us to explore different perspectives 
while interpreting the data. We used convenience sampling in order 
to make sure that the selected participants were representative of 
the variety of views and background to ensure the transferability 
of results.26 The findings from this study are representative of a 
white, mainly female, adult sample who live in the UK and were able 
to speak English. Theoretical saturation was achieved through the 
three mapping sessions; therefore, data collected was stopped as no 
new information was added to the process map.
4.2 | Implications for practice and research
The findings from this study have implications for both clinical practice 
and future research. The process map produced in this study maps 
out the journey of patients and gives an insight to health-care profes-
sionals to understand what patients go through from the first onset 
of their symptoms to the on-going management of achalasia. It also 
provides new insights into the patient's journey from the patient's per-
spective, which could be used to improve the doctor-patient relation-
ship. Understanding the patient's journey from their perspective could 
enable and encourage health-care professionals to tailor the care of 
individuals based on their journey and can also be a useful decision aid 
for health-care professionals. Moreover, it can assist health-care pro-
fessionals for better shared decision making. The results also identified 
that participants felt that they did not receive enough information and 
support throughout their journey and for the long-term management 
of achalasia. Misdiagnosis by the NHS GPs was also very common. 
These findings highlight the need to co-develop patient resources to 
find out what resources, interventions and support patients think they 
would benefit from, along with further GP training. The results from 
this study also identified the key time points and the steps where peo-
ple feel they need additional support. Stress was a key component, 
which triggered patients’ symptoms at different phases, and was high-
lighted as a potential area for future research. A stress management 
programme could be developed as a tool in enabling people to deal 
with the anxiety and stress associated with this condition.
4.3 | Future research
Future studies should design or co-design an intervention with peo-
ple with achalasia to initiate a behaviour change so it can help people 
to self-manage their condition better, and further studies should in-
clude health-care professionals as co-producers of research knowl-
edge (such as doing research collaboratively as opposed to doing 
research on people with achalasia) to underpin further work on de-
veloping interventions to enable better disease management.
5  | CONCLUSION
This study mapped the journey of people with achalasia. The study 
highlighted the issues people faced at each stage in their journey and 
identified the areas that need addressing to help people cope with 
their condition, including interventions to improve patient care. The 
process map also highlighted the importance of self-management of 
chronic conditions. People who participated in this study may have 
undergone different medical treatments, but all of them were still 
experiencing symptoms that required them to adopt different self-
management strategies to carry out their normal lives.
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